AIDS and Behavior

, Volume 21, Issue 7, pp 2101–2123 | Cite as

Challenges in the Evaluation of Interventions to Improve Engagement Along the HIV Care Continuum in the United States: A Systematic Review

  • Kathryn A. Risher
  • Sunaina Kapoor
  • Alice Moji Daramola
  • Gabriela Paz-Bailey
  • Jacek Skarbinski
  • Kate Doyle
  • Kate Shearer
  • David Dowdy
  • Eli Rosenberg
  • Patrick Sullivan
  • Maunank Shah
Substantive Review

Abstract

In the United States (US), there are high levels of disengagement along the HIV care continuum. We sought to characterize the heterogeneity in research studies and interventions to improve care engagement among people living with diagnosed HIV infection. We performed a systematic literature search for interventions to improve HIV linkage to care, retention in care, reengagement in care and adherence to antiretroviral therapy (ART) in the US published from 2007-mid 2015. Study designs and outcomes were allowed to vary in included studies. We grouped interventions into categories, target populations, and whether results were significantly improved. We identified 152 studies, 7 (5%) linkage studies, 33 (22%) retention studies, 4 (3%) reengagement studies, and 117 (77%) adherence studies. ‘Linkage’ studies utilized 11 different outcome definitions, while ‘retention’ studies utilized 39, with very little consistency in effect measurements. The majority (59%) of studies reported significantly improved outcomes, but this proportion and corresponding effect sizes varied substantially across study categories. This review highlights a paucity of assessments of linkage and reengagement interventions; limited generalizability of results; and substantial heterogeneity in intervention types, outcome definitions, and effect measures. In order to make strides against the HIV epidemic in the US, care continuum research must be improved and benchmarked against an integrated, comprehensive framework.

Keywords

HIV care continuum HIV linkage to care HIV retention in care HIV reengagement HIV adherence 

Notes

Acknowledgements

This work was supported by Cooperative Agreement Number 5U38PS004646 by the National Center for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention, as part of the NCHHSTP Epidemiologic and Economic Modeling Cooperative Agreement. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. The authors would like to thank the Applied Public Health Advisory Group, a collaborative set of state and local public health professionals convened for this project, for their guidance and expertise. We would like to specifically thank Dr. Greg Felzein, Thomas Betrand, Nanette Benbow, Dr. Jane Kelly, Dr. David Holtgrave and Dr. Jim Curran for reviewing this paper and providing feedback.

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

10461_2017_1687_MOESM1_ESM.docx (1.5 mb)
Supplementary material 1 (DOCX 1573 kb)

References

  1. 1.
    The Office of National AIDS Policy. National HIV/AIDS Strategy for the United States: Updated to 2020. 2015. https://www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas-update.pdf. Accessed 1 Feb 2016.
  2. 2.
    Sidibé M, Zuniga JM. Leveraging HIV treatment to end AIDS, stop new HIV infections, and avoid the cost of inaction. Clin Infect Dis. 2014;59(Suppl 1):S3–6.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Shah M, Perry A, Risher K, et al. Effect of the US National HIV/AIDS Strategy targets for improved HIV care engagement: a modelling study. Lancet HIV. 2016;3(3):e140–6.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Shah M, Risher K, Berry SA, Dowdy DW. The epidemiologic and economic impact of improving HIV testing, linkage, and retention in care in the United States. Clin Infect Dis. 2016;62(2):220–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Frieden TR, Foti KE, Mermin J. Applying public health principles to the HIV epidemic—how are we doing? N Engl J Med. 2015;373(23):2281–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Bradley H, Hall HI, Wolitski RJ, et al. Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV–United States, 2011. MMWR Morb Mortal Wkly Rep. 2014;63(47):1113–7.PubMedGoogle Scholar
  7. 7.
    Charania MR, Marshall KJ, Lyles CM, et al. Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996–2011. AIDS Behav. 2014;18(4):646–60.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Crepaz N, Baack BN, Higa DH, Mullins MM. Effects of integrated interventions on transmission risk and care continuum outcomes in persons living with HIV: meta-analysis, 1996–2014. AIDS. 2015;29(18):2371–83.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Higa DH, Crepaz N, Mullins MM. Prevention Research Synthesis Project. Identifying best practices for increasing linkage to, retention, and re-engagement in HIV medical care: findings from a systematic review, 1996-2014. AIDS Behav. 2016;20(5):951–66.PubMedCrossRefGoogle Scholar
  10. 10.
    Higa DH, Marks G, Crepaz N, Liau A, Lyles CM. Interventions to improve retention in HIV primary care: a systematic review of U.S. studies. Curr HIV/AIDS Rep. 2012;9(4):313–25.PubMedCrossRefGoogle Scholar
  11. 11.
    Liau A, Crepaz N, Lyles CM, et al. Interventions to promote linkage to and utilization of HIV medical care among HIV-diagnosed persons: a qualitative systematic review, 1996-2011. AIDS Behav. 2013;17(6):1941–62.PubMedCrossRefGoogle Scholar
  12. 12.
    Mathes T, Pieper D, Antoine SL, Eikermann M. Cost-effectiveness of adherence interventions for highly active antiretroviral therapy: a systematic review. Int J Technol Assess Health Care. 2013;29(3):227–33.PubMedCrossRefGoogle Scholar
  13. 13.
    Centers for Disease Control and Prevention. Prevention Resarch Synthesis. 2015. http://www.cdc.gov/hiv/dhap/prb/prs/. Accessed 20 May 2016.
  14. 14.
    Higgins JPT, Altman DG, Stern JAC. Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.1.0. The Cochrane Collaboration; 2011. http://www.cochrane-handbook.org/. Accessed 15 Aug 2015.
  15. 15.
    Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute (OHRI); 2009. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 15 Aug 2015.
  16. 16.
    Gardner LI, Giordano TP, Marks G, et al. Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics. Clin Infect Dis. 2014;59(5):725–34.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Konkle-Parker DJ, Amico KR, McKinney VE. Effects of an intervention addressing information, motivation, and behavioral skills on HIV care adherence in a southern clinic cohort. AIDS Care. 2014;26(6):674–83.PubMedCrossRefGoogle Scholar
  18. 18.
    Konkle-Parker DJ, Erlen JA, Dubbert PM, May W. Pilot testing of an HIV medication adherence intervention in a public clinic in the Deep South. J Am Acad Nurse Pract. 2012;24(8):488–98.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    MacGowan RJ, Lifshay J, Mizuno Y, Johnson WD, McCormick L, Zack B. Positive Transitions (POST): evaluation of an HIV prevention intervention for HIV-positive persons releasing from correctional facilities. AIDS Behav. 2015;19(6):1061–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Lucas GM, Chaudhry A, Hsu J, et al. Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: a randomized trial. Ann Intern Med. 2010;152(11):704–11.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Robbins GK, Lester W, Johnson KL, et al. Efficacy of a clinical decision-support system in an HIV practice: a randomized trial. Ann Intern Med. 2012;157(11):757–66.PubMedCrossRefGoogle Scholar
  22. 22.
    Norton BL, Person AK, Castillo C, Pastrana C, Subramanian M, Stout JE. Barriers to using text message appointment reminders in an HIV clinic. Telemed J E-Health. 2014;20(1):86–9.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Proeschold-Bell RJ, Belden CM, Parnell H, Cohen S, Cromwell M, Lombard F. A randomized controlled trial of health information exchange between human immunodeficiency virus institutions. J Public Health Manag Pract. 2010;16(6):521–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Bove J, Golden MR, Dhanireddy S, Harrington RD, Dombrowski JC. Outcomes of a clinic-based, surveillance-informed intervention to relink patients to HIV care. J Acquir Immune Defic Syndr. 2015;70(3):262–8.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Flash CA, Pasalar S, Hemmige V, et al. Benefits of a routine opt-out HIV testing and linkage to care program for previously diagnosed patients in publicly funded emergency departments in Houston, TX. J Acquir Immune Defic Syndr. 2015;69(Suppl 1):S8–15.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Bradford JB, Coleman S, Cunningham W. HIV System Navigation: an emerging model to improve HIV care access. AIDS Patient Care STDS. 2007;21(Suppl 1):S49–58.PubMedGoogle Scholar
  27. 27.
    Gross R, Bellamy SL, Chapman J, et al. Managed problem solving for antiretroviral therapy adherence: a randomized trial. JAMA Intern Med. 2013;173(4):300–6.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Gross R, Tierney C, Andrade A, et al. Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. Arch Intern Med. 2009;169(13):1224–32.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Hersch RK, Cook RF, Billings DW, et al. Test of a web-based program to improve adherence to HIV medications. AIDS Behav. 2013;17(9):2963–76.PubMedCrossRefGoogle Scholar
  30. 30.
    Holstad MM, DiIorio C, Kelley ME, Resnicow K, Sharma S. Group motivational interviewing to promote adherence to antiretroviral medications and risk reduction behaviors in HIV infected women. AIDS Behav. 2011;15(5):885–96.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Horberg MA, Hurley LB, Silverberg MJ, Kinsman CJ, Quesenberry CP. Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;44(5):531–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Ma A, Chen DM, Chau FM, Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist’s interventions. AIDS Care. 2010;22(10):1189–94.PubMedCrossRefGoogle Scholar
  33. 33.
    Mitchell CG, Freels S, Creticos CM, Oltean A, Douglas R. Preliminary findings of an intervention integrating modified directly observed therapy and risk reduction counseling. AIDS Care. 2007;19(4):561–4.PubMedCrossRefGoogle Scholar
  34. 34.
    Sorensen JL, Haug NA, Larios S, et al. Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance. J Subst Abuse Treat. 2012;43(4):418–23.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Skarbinski J, Rosenberg E, Paz-Bailey G, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175(4):588–96.PubMedCrossRefGoogle Scholar
  36. 36.
    Magnus M, Jones K, Phillips G 2nd, et al. Characteristics associated with retention among African American and Latino adolescent HIV-positive men: results from the outreach, care, and prevention to engage HIV-seropositive young MSM of color special project of national significance initiative. J Acquir Immune Defic Syndr. 2010;53(4):529–36.PubMedCrossRefGoogle Scholar
  37. 37.
    Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr. 2012;60(1):77–82.PubMedCrossRefGoogle Scholar
  38. 38.
    Keller SC, Yehia BR, Eberhart MG, Brady KA. Accuracy of definitions for linkage to care in persons living with HIV. J Acquir Immune Defic Syndr. 2013;63(5):622–30.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Colasanti J, Kelly J, Pennisi E, et al. Continuous retention and viral suppression provide further insights into the HIV care continuum compared to the cross-sectional HIV care cascade. Clin Infect Dis. 2016;62(5):648–54.PubMedCrossRefGoogle Scholar
  40. 40.
    Bocour A, Renaud TC, Udeagu CC, Shepard CW. HIV partner services are associated with timely linkage to HIV medical care. AIDS. 2013;27(18):2961–3.PubMedCrossRefGoogle Scholar
  41. 41.
    Willis S, Castel AD, Ahmed T, Olejemeh C, Frison L, Kharfen M. Linkage, engagement, and viral suppression rates among HIV-infected persons receiving care at medical case management programs in Washington, DC. J Acquir Immune Defic Syndr. 2013;64(Suppl 1):S33–41.PubMedCrossRefGoogle Scholar
  42. 42.
    Keller S, Jones J, Erbelding E. Choice of rapid HIV testing and entrance into care in Baltimore City sexually transmitted infections clinics. AIDS Patient Care STDS. 2011;25(4):237–43.PubMedCrossRefGoogle Scholar
  43. 43.
    Craw JA, Gardner LI, Marks G, et al. Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr. 2008;47(5):597–606.PubMedCrossRefGoogle Scholar
  44. 44.
    Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med. 2008;16(5):156–61.PubMedGoogle Scholar
  45. 45.
    Castel AD, Greenberg AE, Befus M, et al. Temporal association between expanded HIV testing and improvements in population-based HIV/AIDS clinical outcomes, District of Columbia. AIDS Care. 2014;26(6):785–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Onyeajam DJ, Eke R, Stephens TG, Duffus WA. Time to linkage to care and viro-immunologic parameters of individuals diagnosed before and after the 2006 HIV testing recommendations. South Med J. 2013;106(4):257–66.PubMedCrossRefGoogle Scholar
  47. 47.
    Shrestha RK, Gardner L, Marks G, et al. Estimating the cost of increasing retention in care for HIV-infected patients: results of the CDC/HRSA retention in care trial. J Acquir Immune Defic Syndr. 2015;68(3):345–50.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Gwadz M, Cleland CM, Applegate E, et al. Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention. AIDS Behav. 2015;19(10):1801–17.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Naar-King S, Outlaw A, Green-Jones M, Wright K, Parsons JT. Motivational interviewing by peer outreach workers: a pilot randomized clinical trial to retain adolescents and young adults in HIV care. AIDS Care. 2009;21(7):868–73.PubMedCrossRefGoogle Scholar
  50. 50.
    Purcell DW, Latka MH, Metsch LR, et al. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007;46(Suppl 2):S35–47.PubMedCrossRefGoogle Scholar
  51. 51.
    Wohl DA, Scheyett A, Golin CE, et al. Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial. AIDS Behav. 2011;15(2):356–64.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Wolitski RJ, Kidder DP, Pals SL, et al. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS Behav. 2010;14(3):493–503.PubMedCrossRefGoogle Scholar
  53. 53.
    Altice FL, Bruce RD, Lucas GM, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S22–32.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Bogart LM, Wagner GJ, Mutchler MG, et al. Community HIV treatment advocacy programs may support treatment adherence. AIDS Educ Prev. 2012;24(1):1–14.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Cabral HJ, Tobias C, Rajabiun S, et al. Outreach program contacts: do they increase the likelihood of engagement and retention in HIV primary care for hard-to-reach patients? AIDS Patient Care STDS. 2007;21(Suppl 1):S59–67.PubMedGoogle Scholar
  56. 56.
    Cunningham CO, Sohler NL, Cooperman NA, Berg KM, Litwin AH, Arnsten JH. Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users. Subst Use Misuse. 2011;46(2–3):218–32.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Davila JA, Miertschin N, Sansgiry S, Schwarzwald H, Henley C, Giordano TP. Centralization of HIV services in HIV-positive African-American and Hispanic youth improves retention in care. AIDS Care. 2013;25(2):202–6.PubMedCrossRefGoogle Scholar
  58. 58.
    Hanna DB, Buchacz K, Gebo KA, et al. Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001–2009. PLoS ONE. 2013;8(11):e78952.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Himelhoch S, Brown CH, Walkup J, et al. HIV patients with psychiatric disorders are less likely to discontinue HAART. AIDS. 2009;23(13):1735–42.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Schranz AJ, Brady KA, Momplaisir F, Metlay JP, Stephens A, Yehia BR. Comparison of HIV outcomes for patients linked at hospital versus community-based clinics. AIDS Patient Care STDS. 2015;29(3):117–25.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Terzian AS, Irvine MK, Hollod LM, Lim S, Rojas J, Shepard CW. Effect of HIV housing services on engagement in care and treatment, New York City, 2011. AIDS Behav. 2015;19(11):2087–96.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Andersen M, Hockman E, Smereck G, et al. Retaining women in HIV medical care. J Assoc Nurses AIDS Care. 2007;18(3):33–41.PubMedCrossRefGoogle Scholar
  63. 63.
    Enriquez M, Farnan R, Cheng AL, et al. Impact of a bilingual/bicultural care team on HIV-related health outcomes. J Assoc Nurses AIDS Care. 2008;19(4):295–301.PubMedCrossRefGoogle Scholar
  64. 64.
    Henry SR, Goetz MB, Asch SM. The effect of automated telephone appointment reminders on HIV primary care no-shows by veterans. J Assoc Nurses AIDS Care. 2012;23(5):409–18.PubMedCrossRefGoogle Scholar
  65. 65.
    Hightow-Weidman LB, Smith JC, Valera E, Matthews DD, Lyons P. Keeping them in “STYLE”: finding, linking, and retaining young HIV-positive black and Latino men who have sex with men in care. AIDS Patient Care STDS. 2011;25(1):37–45.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Irvine MK, Chamberlin SA, Robbins RS, et al. Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program. Clin Infect Dis. 2015;60(2):298–310.PubMedCrossRefGoogle Scholar
  67. 67.
    Saifu HN, Asch SM, Goetz MB, et al. Evaluation of human immunodeficiency virus and hepatitis C telemedicine clinics. Am J Manag Care. 2012;18(4):207–12.PubMedGoogle Scholar
  68. 68.
    Shade SB, Steward WT, Koester KA, Chakravarty D, Myers JJ. Health information technology interventions enhance care completion, engagement in HIV care and treatment, and viral suppression among HIV-infected patients in publicly funded settings. J Am Med Inf Assoc. 2015;22(e1):e104–11.Google Scholar
  69. 69.
    Gardner LI, Marks G, Craw JA, et al. A low-effort, clinic-wide intervention improves attendance for HIV primary care. Clin Infect Dis. 2012;55(8):1124–34.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Gardner LI, Marks G, Wilson TE, et al. Clinic-wide intervention lowers financial risk and improves revenue to HIV clinics through fewer missed primary care visits. J Acquir Immune Defic Syndr. 2015;68(4):472–6.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Magnus M, Herwehe J, Gruber D, et al. Improved HIV-related outcomes associated with implementation of a novel public health information exchange. Int J Med Inform. 2012;81(10):e30–8.PubMedCrossRefGoogle Scholar
  72. 72.
    Kapadia F, Vlahov D, Wu Y, et al. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse. 2008;34(2):161–70.PubMedCrossRefGoogle Scholar
  73. 73.
    Sacks S, McKendrick K, Vazan P, Sacks JY, Cleland CM. Modified therapeutic community aftercare for clients triply diagnosed with HIV/AIDS and co-occurring mental and substance use disorders. AIDS Care. 2011;23(12):1676–86.PubMedCrossRefGoogle Scholar
  74. 74.
    Springer SA, Qiu J, Saber-Tehrani AS, Altice FL. Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. PLoS ONE. 2012;7(5):e38335.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Springer SA, Chen S, Altice FL. Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health. 2010;87(4):592–602.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Barnett PG, Sorensen JL, Wong W, Haug NA, Hall SM. Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV. Drug Alcohol Depend. 2009;100(1–2):115–21.PubMedCrossRefGoogle Scholar
  77. 77.
    Farber S, Tate J, Frank C, et al. A study of financial incentives to reduce plasma HIV RNA among patients in care. AIDS Behav. 2013;17(7):2293–300.PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Moore BA, Rosen MI, Wang Y, et al. A remotely-delivered CBT and contingency management therapy for substance using people with HIV. AIDS Behav. 2015;19(Suppl 2):156–62.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Petry NM, Weinstock J, Alessi SM, Lewis MW, Dieckhaus K. Group-based randomized trial of contingencies for health and abstinence in HIV patients. J Consult Clin Psychol. 2010;78(1):89–97.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Rosen MI, Dieckhaus K, McMahon TJ, et al. Improved adherence with contingency management. AIDS Patient Care STDS. 2007;21(1):30–40.PubMedCrossRefGoogle Scholar
  81. 81.
    Sorensen JL, Haug NA, Delucchi KL, et al. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007;88(1):54–63.PubMedCrossRefGoogle Scholar
  82. 82.
    Feaster DJ, Brincks AM, Mitrani VB, Prado G, Schwartz SJ, Szapocznik J. The efficacy of Structural Ecosystems Therapy for HIV medication adherence with African American women. J Fam Psychol. 2010;24(1):51–9.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Feaster DJ, Mitrani VB, Burns MJ, et al. A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention. Drug Alcohol Depend. 2010;111(3):227–34.PubMedPubMedCentralCrossRefGoogle Scholar
  84. 84.
    Hawk M, Davis D. The effects of a harm reduction housing program on the viral loads of homeless individuals living with HIV/AIDS. AIDS Care. 2012;24(5):577–82.PubMedCrossRefGoogle Scholar
  85. 85.
    Johnston SS, Juday T, Seekins D, Espindle D, Chu BC. Association between prescription cost sharing and adherence to initial combination antiretroviral therapy in commercially insured antiretroviral-naive patients with HIV. J Manag Care Pharm. 2012;18(2):129–45.PubMedGoogle Scholar
  86. 86.
    Reznick OG, McCartney K, Gregorich SE, Zack B, Feaster DJ. An ecosystem-based intervention to reduce HIV transmission risk and increase medication adherence among inmates being released to the community. J Correct Health Care. 2013;19(3):178–93.PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    DuChane J, Clark B, Hou J, Fitzner K, Pietrandoni G, Duncan I. Impact of HIV-specialized pharmacies on adherence to medications for comorbid conditions. J Am Pharm Assoc (2003). 2014;54(5):493–501.Google Scholar
  88. 88.
    Henderson KC, Hindman J, Johnson SC, Valuck RJ, Kiser JJ. Assessing the effectiveness of pharmacy-based adherence interventions on antiretroviral adherence in persons with HIV. AIDS Patient Care STDS. 2011;25(4):221–8.PubMedCrossRefGoogle Scholar
  89. 89.
    Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries. J Manag Care Pharm. 2009;15(1):32–41.PubMedGoogle Scholar
  90. 90.
    Hirsch JD, Gonzales M, Rosenquist A, Miller TA, Gilmer TP, Best BM. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS. J Manag Care Pharm. 2011;17(3):213–23.PubMedGoogle Scholar
  91. 91.
    March K, Mak M, Louie SG. Effects of pharmacists’ interventions on patient outcomes in an HIV primary care clinic. Am J Health Syst Pharm. 2007;64(24):2574–8.PubMedCrossRefGoogle Scholar
  92. 92.
    Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012;26(9):526–31.PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Khan M, Song X, Williams K, Bright K, Sill A, Rakhmanina N. Evaluating adherence to medication in children and adolescents with HIV. Arch Dis Child. 2009;94(12):970–3.PubMedCrossRefGoogle Scholar
  94. 94.
    Preininger L, Cantwell-McNelis K, James C, Sullivan MC, Szabo S, Bincsik A. Long-term medication adherence in patients receiving antiretroviral drug therapy. Curr HIV Res. 2011;9(4):253–5.PubMedCrossRefGoogle Scholar
  95. 95.
    Belzer ME, Kolmodin MacDonell K, Clark LF, et al. Acceptability and feasibility of a cell phone support intervention for youth living with HIV with nonadherence to antiretroviral therapy. AIDS Patient Care STDS. 2015;29(6):338–45.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Lewis MA, Uhrig JD, Bann CM, et al. Tailored text messaging intervention for HIV adherence: a proof-of-concept study. Health Psychol. 2013;32(3):248–53.PubMedCrossRefGoogle Scholar
  97. 97.
    Belzer ME, Naar-King S, Olson J, et al. The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial. AIDS Behav. 2014;18(4):686–96.PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Dowshen N, Kuhns LM, Johnson A, Holoyda BJ, Garofalo R. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res. 2012;14(2):e51.PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Hardy H, Kumar V, Doros G, et al. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS. 2011;25(3):153–61.PubMedPubMedCentralGoogle Scholar
  100. 100.
    Moore DJ, Poquette A, Casaletto KB, et al. Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder. AIDS Behav. 2015;19(3):459–71.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Pellowski JA, Kalichman SC, White D, Amaral CM, Hoyt G, Kalichman MO. Real-time medication adherence monitoring intervention: test of concept in people living with HIV infection. J Assoc Nurses AIDS Care. 2014;25(6):646–51.PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Simoni JM, Huh D, Frick PA, et al. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial. J Acquir Immune Defic Syndr. 2009;52(4):465–73.PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Dieckhaus KD, Odesina V. Outcomes of a multifaceted medication adherence intervention for HIV-positive patients. AIDS Patient Care STDS. 2007;21(2):81–91.PubMedCrossRefGoogle Scholar
  104. 104.
    Nahvi S, Litwin AH, Heo M, Berg KM, Li X, Arnsten JH. Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence. Drug Alcohol Depend. 2012;120(1–3):174–80.PubMedCrossRefGoogle Scholar
  105. 105.
    Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908–15.PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Page TF, Horvath KJ, Danilenko GP, Williams M. A cost analysis of an Internet-based medication adherence intervention for people living with HIV. J Acquir Immune Defic Syndr. 2012;60(1):1–4.PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Blank MB, Hanrahan NP, Fishbein M, et al. A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illness. Psychiatr Serv. 2011;62(11):1318–24.PubMedPubMedCentralCrossRefGoogle Scholar
  108. 108.
    Enriquez M, Cheng AL, Banderas J, et al. A peer-led HIV medication adherence intervention targeting adults linked to medical care but without a suppressed viral load. J Int Assoc Provid AIDS Care. 2014;14(5):441–8.PubMedCrossRefGoogle Scholar
  109. 109.
    Horvath KJ, Oakes JM, Rosser BR, et al. Feasibility, acceptability and preliminary efficacy of an online peer-to-peer social support ART adherence intervention. AIDS Behav. 2013;17(6):2031–44.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Kenya S, Jones J, Arheart K, et al. Using community health workers to improve clinical outcomes among people living with HIV: a randomized controlled trial. AIDS Behav. 2013;17(9):2927–34.PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Koenig LJ, Pals SL, Bush T, Pratt Palmore M, Stratford D, Ellerbrock TV. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol. 2008;27(2):159–69.PubMedCrossRefGoogle Scholar
  112. 112.
    Simoni JM, Pantalone DW, Plummer MD, Huang B. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007;26(4):488–95.PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Altice FL, Maru DS, Bruce RD, Springer SA, Friedland GH. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis. 2007;45(6):770–8.PubMedPubMedCentralCrossRefGoogle Scholar
  114. 114.
    Berg KM, Litwin AH, Li X, Heo M, Arnsten JH. Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention. Clin Infect Dis. 2011;53(9):936–43.PubMedPubMedCentralCrossRefGoogle Scholar
  115. 115.
    Berg KM, Litwin A, Li X, Heo M, Arnsten JH. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial. Drug Alcohol Depend. 2011;113(2–3):192–9.PubMedCrossRefGoogle Scholar
  116. 116.
    Gaur AH, Belzer M, Britto P, et al. Directly observed therapy (DOT) for nonadherent HIV-infected youth: lessons learned, challenges ahead. AIDS Res Hum Retroviruses. 2010;26(9):947–53.PubMedPubMedCentralCrossRefGoogle Scholar
  117. 117.
    Glikman D, Walsh L, Valkenburg J, Mangat PD, Marcinak JF. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications. Pediatrics. 2007;119(5):e1142–8.PubMedCrossRefGoogle Scholar
  118. 118.
    Lucas GM, Mullen BA, Galai N, et al. Directly administered antiretroviral therapy for HIV-infected individuals in opioid treatment programs: results from a randomized clinical trial. PLoS ONE. 2013;8(7):e68286.PubMedPubMedCentralCrossRefGoogle Scholar
  119. 119.
    Ma M, Brown BR, Coleman M, Kibler JL, Loewenthal H, Mitty JA. The feasibility of modified directly observed therapy for HIV-seropositive African American substance users. AIDS Patient Care STDS. 2008;22(2):139–46.PubMedCrossRefGoogle Scholar
  120. 120.
    Macalino GE, Hogan JW, Mitty JA, et al. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS. 2007;21(11):1473–7.PubMedCrossRefGoogle Scholar
  121. 121.
    Maru DS, Bruce RD, Walton M, Springer SA, Altice FL. Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial. J Acquir Immune Defic Syndr. 2009;50(2):176–81.PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Mitty JA, Huang D, Loewenthal HG, MacLeod C, Thompson L, Bazerman LB. Modified directly observed therapy: sustained self-reported adherence and HIV health status. AIDS Patient Care STDS. 2007;21(12):897–9.PubMedCrossRefGoogle Scholar
  123. 123.
    White BL, Golin CE, Grodensky CA, et al. Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study. AIDS Behav. 2015;19(1):128–36.PubMedPubMedCentralCrossRefGoogle Scholar
  124. 124.
    Giordano TP, Rodriguez S, Zhang H, et al. Effect of a clinic-wide social marketing campaign to improve adherence to antiretroviral therapy for HIV infection. AIDS Behav. 2013;17(1):104–12.PubMedPubMedCentralCrossRefGoogle Scholar
  125. 125.
    Horberg MA, Hurley LB, Towner WJ, et al. Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2012;60(2):183–90.PubMedPubMedCentralCrossRefGoogle Scholar
  126. 126.
    Keith McInnes D, Shimada SL, Rao SR, et al. Personal health record use and its association with antiretroviral adherence: survey and medical record data from 1871 US veterans infected with HIV. AIDS Behav. 2013;17(9):3091–100.PubMedCrossRefGoogle Scholar
  127. 127.
    Saberi P, Catz SL, Leyden WA, et al. Antiretroviral therapy adherence and use of an electronic shared medical record among people living with HIV. AIDS Behav. 2015;19(Suppl 2):177–85.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Wilson IB, Laws MB, Safren SA, et al. Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV. J Acquir Immune Defic Syndr. 2010;53(3):338–47.PubMedPubMedCentralCrossRefGoogle Scholar
  129. 129.
    Rasu RS, Malewski DF, Banderas JW, Malomo Thomson D, Goggin K. Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2013;63(1):e1–8.PubMedPubMedCentralCrossRefGoogle Scholar
  130. 130.
    Ingersoll KS, Farrell-Carnahan L, Cohen-Filipic J, et al. A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users. Drug Alcohol Depend. 2011;116(1–3):177–87.PubMedPubMedCentralCrossRefGoogle Scholar
  131. 131.
    Johnson MO, Charlebois E, Morin SF, Remien RH, Chesney MA. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study. J Acquir Immune Defic Syndr. 2007;46(5):574–80.PubMedPubMedCentralCrossRefGoogle Scholar
  132. 132.
    Johnson MO, Dilworth SE, Taylor JM, Neilands TB. Improving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV. Ann Behav Med. 2011;41(1):83–91.PubMedCrossRefGoogle Scholar
  133. 133.
    Jones DL, McPherson-Baker S, Lydston D, et al. Efficacy of a group medication adherence intervention among HIV positive women: the SMART/EST Women’s Project. AIDS Behav. 2007;11(1):79–86.PubMedPubMedCentralCrossRefGoogle Scholar
  134. 134.
    Kalichman SC, Cherry C, Kalichman MO, et al. Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission. Am J Public Health. 2011;101(3):531–8.PubMedPubMedCentralCrossRefGoogle Scholar
  135. 135.
    Kalichman SC, Kalichman MO, Cherry C, et al. Brief behavioral self-regulation counseling for HIV treatment adherence delivered by cell phone: an initial test of concept trial. AIDS Patient Care STDS. 2011;25(5):303–10.PubMedPubMedCentralCrossRefGoogle Scholar
  136. 136.
    Kalichman SC, Cherry C, Kalichman MO, et al. Randomized clinical trial of HIV treatment adherence counseling interventions for people living with HIV and limited health literacy. J Acquir Immune Defic Syndr. 2013;63(1):42–50.PubMedPubMedCentralCrossRefGoogle Scholar
  137. 137.
    Letourneau EJ, Ellis DA, Naar-King S, Chapman JE, Cunningham PB, Fowler S. Multisystemic therapy for poorly adherent youth with HIV: results from a pilot randomized controlled trial. AIDS Care. 2013;25(4):507–14.PubMedCrossRefGoogle Scholar
  138. 138.
    Murphy DA, Marelich WD, Rappaport NB, Hoffman D, Farthing C. Results of an antiretroviral adherence intervention: STAR (Staying Healthy: Taking Antiretrovirals Regularly). J Int Assoc Physicians AIDS Care (Chic). 2007;6(2):113–24.CrossRefGoogle Scholar
  139. 139.
    Naar-King S, Parsons JT, Murphy DA, Chen X, Harris DR, Belzer ME. Improving health outcomes for youth living with the human immunodeficiency virus: a multisite randomized trial of a motivational intervention targeting multiple risk behaviors. Arch Pediatr Adolesc Med. 2009;163(12):1092–8.PubMedPubMedCentralCrossRefGoogle Scholar
  140. 140.
    Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007;46(4):443–50.PubMedPubMedCentralCrossRefGoogle Scholar
  141. 141.
    Reich WA. Medication adherence feedback intervention predicts improved human immunodeficiency virus clinical markers. Int J Nurs Pract. 2013;19(6):577–83.PubMedCrossRefGoogle Scholar
  142. 142.
    Reynolds NR, Testa MA, Su M, et al. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Syndr. 2008;47(1):62–8.PubMedCrossRefGoogle Scholar
  143. 143.
    Robbins GK, Testa MA, Su M, et al. Site nurse-initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: substudy of ACTG 384. HIV Clin Trials. 2013;14(5):235–53.PubMedPubMedCentralCrossRefGoogle Scholar
  144. 144.
    Roth AM, Holmes AM, Stump TE, et al. Can lay health workers promote better medical self-management by persons living with HIV? An evaluation of the Positive Choices program. Patient Educ Couns. 2012;89(1):184–90.PubMedCrossRefGoogle Scholar
  145. 145.
    Safren SA, O’Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28(1):1–10.PubMedPubMedCentralCrossRefGoogle Scholar
  146. 146.
    Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–15.PubMedPubMedCentralCrossRefGoogle Scholar
  147. 147.
    Skrajner MJ, Camp CJ, Haberman JL, Heckman TG, Kochman A, Frentiu C. Use of videophone technology to address medication adherence issues in persons with HIV. HIV AIDS (Auckl). 2009;1:23–30.PubMedPubMedCentralGoogle Scholar
  148. 148.
    Tetrault JM, Moore BA, Barry DT, et al. Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. J Subst Abuse Treat. 2012;43(4):433–9.PubMedCrossRefGoogle Scholar
  149. 149.
    Wagner GJ, Lovely P, Schneider S. Pilot controlled trial of the adherence readiness program: an intervention to assess and sustain HIV antiretroviral adherence readiness. AIDS Behav. 2013;17(9):3059–65.PubMedCrossRefGoogle Scholar
  150. 150.
    Webel AR. Testing a peer-based symptom management intervention for women living with HIV/AIDS. AIDS Care. 2010;22(9):1029–40.PubMedPubMedCentralCrossRefGoogle Scholar
  151. 151.
    Cooperman NA, Heo M, Berg KM, et al. Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users. AIDS Care. 2012;24(7):828–35.PubMedPubMedCentralCrossRefGoogle Scholar
  152. 152.
    DiIorio C, McCarty F, Resnicow K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS care. 2008;20(3):273–83.PubMedPubMedCentralCrossRefGoogle Scholar
  153. 153.
    Goggin K, Gerkovich MM, Williams KB, et al. A randomized controlled trial examining the efficacy of motivational counseling with observed therapy for antiretroviral therapy adherence. AIDS Behav. 2013;17(6):1992–2001.PubMedPubMedCentralCrossRefGoogle Scholar
  154. 154.
    Weiss SM, Tobin JN, Antoni M, et al. Enhancing the health of women living with HIV: the SMART/EST Women’s Project. Int J Womens Health. 2011;3:63–77.PubMedPubMedCentralCrossRefGoogle Scholar
  155. 155.
    Bova C, Burwick TN, Quinones M. Improving women’s adjustment to HIV infection: results of the Positive Life Skills Workshop Project. J Assoc Nurses AIDS Care. 2008;19(1):58–65.PubMedCrossRefGoogle Scholar
  156. 156.
    Enriquez M, Cheng AL, McKinsey DS, Stanford J. Development and efficacy of an intervention to enhance readiness for adherence among adults who had previously failed HIV treatment. AIDS Patient Care STDS. 2009;23(3):177–84.PubMedCrossRefGoogle Scholar
  157. 157.
    Ownby RL, Waldrop-Valverde D, Jacobs RJ, Acevedo A, Caballero J. Cost effectiveness of a computer-delivered intervention to improve HIV medication adherence. BMC Med Inform Decis Mak. 2013;13:29.PubMedPubMedCentralCrossRefGoogle Scholar
  158. 158.
    Brock TP, Smith SR. Using digital videos displayed on personal digital assistants (PDAs) to enhance patient education in clinical settings. Int J Med Inform. 2007;76(11–12):829–35.PubMedCrossRefGoogle Scholar
  159. 159.
    Claborn KR, Leffingwell TR, Miller MB, Meier E, Stephens JR. Pilot study examining the efficacy of an electronic intervention to promote HIV medication adherence. AIDS Care. 2014;26(3):404–9.PubMedCrossRefGoogle Scholar
  160. 160.
    Fisher JD, Amico KR, Fisher WA, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav. 2011;15(8):1635–46.PubMedCrossRefGoogle Scholar
  161. 161.
    Garvie PA, Lensing S, Rai SN. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS. Pediatrics. 2007;119(4):e893–9.PubMedCrossRefGoogle Scholar
  162. 162.
    Holstad MM, Ofotokun I, Higgins M, Logwood S. The LIVE Network: a music-based messaging program to promote ART adherence self-management. AIDS Behav. 2013;17(9):2954–62.PubMedPubMedCentralCrossRefGoogle Scholar
  163. 163.
    Kurth AE, Spielberg F, Cleland CM, et al. Computerized counseling reduces HIV-1 viral load and sexual transmission risk: findings from a randomized controlled trial. J Acquir Immune Defic Syndr. 2014;65(5):611–20.PubMedPubMedCentralCrossRefGoogle Scholar
  164. 164.
    Lopez E, Jones DL, Ishii M, Tobin JN, Weiss SM. HIV medication adherence and substance use: the Smartest Women’s Project. Am J Infect Dis. 2007;3(4):240–7.PubMedPubMedCentralCrossRefGoogle Scholar
  165. 165.
    Naar-King S, Outlaw AY, Sarr M, et al. Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment. J Pediatr Psychol. 2013;38(6):638–48.PubMedPubMedCentralCrossRefGoogle Scholar
  166. 166.
    Ownby RL, Waldrop-Valverde D, Caballero J, Jacobs RJ. Baseline medication adherence and response to an electronically delivered health literacy intervention targeting adherence. Neurobehav HIV Med. 2012;4:113–21.PubMedPubMedCentralCrossRefGoogle Scholar
  167. 167.
    Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47(3):384–90.PubMedCrossRefGoogle Scholar
  168. 168.
    Pyne JM, Fortney JC, Curran GM, et al. Effectiveness of collaborative care for depression in human immunodeficiency virus clinics. Arch Intern Med. 2011;171(1):23–31.PubMedGoogle Scholar
  169. 169.
    Tsai AC, Karasic DH, Hammer GP, et al. Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health. 2013;103(2):308–15.PubMedPubMedCentralCrossRefGoogle Scholar
  170. 170.
    Teixeira PA, Jordan AO, Zaller N, Shah D, Venters H. Health outcomes for HIV-infected persons released from the New York City jail system with a transitional care-coordination plan. Am J Public Health. 2015;105(2):351–7.PubMedPubMedCentralCrossRefGoogle Scholar
  171. 171.
    Kalichman SC, Amaral C, Swetsze C, et al. Monthly unannounced pill counts for monitoring HIV treatment adherence: tests for self-monitoring and reactivity effects. HIV Clin Trials. 2010;11(6):325–31.PubMedCrossRefGoogle Scholar
  172. 172.
    Westling E, Garcia K, Mann T. Discovery of meaning and adherence to medications in HIV-infected women. J Health Psychol. 2007;12(4):627–35.PubMedCrossRefGoogle Scholar
  173. 173.
    Centers for Disease Control and Prevention. HIV Surveillance Report, 2012. 2014. http://www.cdc.gov/hiv/library/reports/surveillance/. Accessed 1 Feb 2016.

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Kathryn A. Risher
    • 1
  • Sunaina Kapoor
    • 2
  • Alice Moji Daramola
    • 3
  • Gabriela Paz-Bailey
    • 4
  • Jacek Skarbinski
    • 4
  • Kate Doyle
    • 4
  • Kate Shearer
    • 1
  • David Dowdy
    • 1
  • Eli Rosenberg
    • 3
  • Patrick Sullivan
    • 3
  • Maunank Shah
    • 2
  1. 1.Department of EpidemiologyJohns Hopkins University Bloomberg School of Public HealthBaltimoreUSA
  2. 2.Division of Infectious DiseasesJohns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Department of EpidemiologyEmory University Rollins School of Public HealthAtlantaUSA
  4. 4.Division of HIV/AIDS PreventionCenters for Disease Control and PreventionAtlantaUSA

Personalised recommendations